Effect of community comprehensive treatment on quality of life of patients with diabetes nephropathy
社区综合治疗对糖尿病肾病患者生活质量的影响观察

摘要

目的 回顾分析糖尿病肾病患者中应用社区综合治疗的作用。方法 纳入时间为 2022 年 1 月到 2022 年 12 月，将该时间段糖尿病肾病患者 71 例进行研究讨论，通过随机分配法安排为对照组（37 例实施常规治疗 方案）、观察组（34 例实施社区综合治疗方案），分析治疗结果。结果 观察组各项生活质量评分高于对照组， 统计学结果 P<0.05，差异较大。观察组各项糖脂代谢指标均低于对照组，统计学结果 P<0.05，差异较大。观察 组各项胰岛功能指标低于对照组，统计学结果 P<0.05，差异较大。结论 于糖尿病肾病患者中应用社区综合治疗， 可帮助患者将临床指标控制在合理范围，提高生活质量。

Abstract

Objective To retrospectively analyze the role of community comprehensive treatment in patients with diabetes nephropathy.
Methods From January 2022 to December 2022, 71 patients with diabetes nephropathy in this period were studied and discussed, and randomly assigned into the control group (37 patients were treated with conventional treatment) and the observation group (34 patients were treated with community comprehensive treatment) to analyze the treatment results. Result The quality of life scores of the observation group were higher than those of the control group, with a statistical result of P<0.05, indicating a significant difference. The various indicators of glucose and lipid metabolism in the observation group were lower than those in the control group, with a statistical result of P<0.05, indicating a significant difference. The observation group had lower islet function indicators than the control group, with a statistical result of P<0.05, indicating a significant difference.
Conclusion   The application of community comprehensive treatment in patients with diabetes nephropathy can help patients control clinical indicators in a reasonable range and improve their quality of life.